Fung-Leung W P, Mak T W
R.W. Johnson Pharmaceutical Research Institute, Toronto, Canada.
Curr Opin Immunol. 1992 Apr;4(2):189-94. doi: 10.1016/0952-7915(92)90012-4.
Mice with defined genetic defects can now be generated using gene targeting technology based on the successful generation of mouse embryonic stem cells with the potential for germ line transmission, and the development of methods for detection of homologous recombination.
基于具有种系传递潜能的小鼠胚胎干细胞的成功培育以及同源重组检测方法的发展,现在可以利用基因靶向技术培育出具有特定基因缺陷的小鼠。